CoChat

Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger

Open access
Boisier, P., Nicolas, P., Djibo, S., Taha, M.-K., Jeanne, I., Mainassara, H. B., Tenebray, B., Kairo, K. K., Giorgini, D., Chanteau, S. · 2007 · Clinical Infectious Diseases

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

BACKGROUND: In Niger, epidemic meningococcal meningitis is primarily caused by Neisseria meningitidis (Nm) serogroup A. However, since 2002, Nm serogroup W135 has been considered to be a major threat that has not yet been realized, and an unprecedented incidence of Nm serogroup X (NmX) meningitis was observed in 2006. METHODS: Meningitis surveillance in Niger is performed on the basis of reporting of clinically suspected cases. Cerebrospinal fluid specimens are sent to the reference laboratory in Niamey, Niger. Culture, latex agglutination, and polymerase chain reaction are used whenever appropriate. Since 2004, after the addition of a polymerase chain reaction-based nonculture assay that was developed to genogroup isolates of NmX, polymerase chain reaction testing allows for the identification of Nm serogroup A, Nm serogroup B, Nm serogroup C, NmX, Nm serogroup Y, and Nm serogroup W135. RESULTS: From January to June 2006, a total of 4185 cases of meningitis were reported, and 2905 cerebrospinal fluid specimens were laboratory tested. NmX meningitis represented 51% of 1139 confirmed cases of meningococcal meningitis, but in southwestern Niger, it represented 90%. In the agglomeration of Niamey, the reported cumulative incidence of meningitis was 73 cases per 100,000 population and the cumulative incidence of confirmed NmX meningitis was 27.5 cases per 100,000 population (74.6 cases per 100,000 population in children aged 5-9 years). NmX isolates had the same phenotype (X : NT : P1.5), and all belonged to the same sequence type (ST-181) as the NmX isolates that were circulating in Niamey in the 1990s. Nm serogroup W135 represented only 2.1% of identified meningococci. CONCLUSIONS: This is, to our knowledge, the first report of such a high incidence of NmX meningitis, although an unusually high incidence of NmX meningitis was also observed in the 1990s in Niamey. The increasing incidence of NmX meningitis is worrisome, because no vaccine has been developed against this serogroup. Countries in the African meningitis belt must prepare to face this potential new challenge.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/511646

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Research works printed but not linked: 10

  1. Koumare B, Bougoudogo F, Cisse M, Doumbia T, Keita MM. Bacte- riological aspects of purulent meningitis in Bamako district: a propos of 1541 bacterial strains collected from 1979 to 1991 [in French]. Bull Soc Pathol Exot 1993; 86:136-40.
  2. 1993, Bulletin de la Soci t de pathologie exotique (1990), 86, 136
  3. Gagneux SP, Hodgson A, Smith TA, et al. Prospective study of a se- rogroup X Neisseria meningitidis outbreak in northern Ghana. J Infect Dis 2002; 185:618-26.
  4. Parent du Chatelet I, Traore Y, Gessner BD, et al. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain re- action testing. Clin Infect Dis 2005; 40:17-25.
  5. World Health Organization. Meningococcal disease, serogroup W135, Burkina Faso: preliminary report, 2002. Wkly Epidemiol Rec 2002; 77: 152-5.
  6. World Health Organization (WHO). Enhanced surveillance of epi- demic meningococcal meningitis in Africa: a three-year experience. Wkly Epidemiol Rec 2005; 80:313-20.
  7. 2002, Weekly epidemiological record / Health Section of the Secretariat of the League of Nations, 77, 152
  8. 2005, Weekly epidemiological record / Health Section of the Secretariat of the League of Nations, 80, 313
  9. Multi Disease Surveillance Centre (MDSC). Epidemiological situation of week 22 to 26, 2006. MDSC Meningitis Weekly Bulletin. Ouaga- dougou: World Health Organization-Regional Office for Africa, 2006.
  10. Traore Y, Njanpop-Lafourcade BM, Adjogble KL, et al. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis 2006; 43:817-22.

Cited by

Metadata

Authors
Boisier, P., Nicolas, P., Djibo, S., Taha, M.-K., Jeanne, I., Mainassara, H. B., Tenebray, B., Kairo, K. K., Giorgini, D., & Chanteau, S.
Affiliations
  • Centre de Recherche Médicale et Sanitaire (NE)
  • World Health Organization (CH)
  • Institut Pasteur (FR)
  • Ministère de la Santé Publique (NE)
Corresponding author
Boisier, P.
Venue
Clinical Infectious Diseases
Published
2007-03-01
Volume
44
Issue
5
Pages
657-663
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2159099211
Cited by
237
References
26
Citations by year
2026: 3 · 2025: 5 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 8 · 2018: 12 · 2017: 12 · 2016: 15 · 2015: 14 · 2014: 21 · 2013: 23 · 2012: 34
FWCI
16.38
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • Own your potential (DEAKIN) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • World Health Organization
  • Wellcome Trust
  • University of Oxford
  • European Commission
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
Keywords
meningococcal meningitis, serogroup W135, epidemic meningitis, meningitis incidence, Niger, Niamey, serogroup replacement, children aged 5-9 years
MeSH terms
Disease Outbreaks, Humans, Meningitis, Meningococcal, Neisseria meningitidis, Niger, Serotyping, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.